BLUE BIOFUELS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BLUE BIOFUELS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($422.5K) | Oct 23, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($920.8K) | Oct 23, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($920.8K) | Jul 31, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($243.8K) | Oct 23, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($243.8K) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($243.8K) | Apr 30, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $1.87M | Oct 23, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($548.8K) | Oct 23, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($548.8K) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($946.9K) | Apr 30, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($946.9K) | Jul 31, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($946.9K) | Oct 23, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($332.0K) | Nov 4, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.15M) | Aug 8, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($1.15M) | Nov 4, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($1.06M) | Nov 4, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.06M) | May 20, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($1.06M) | Aug 8, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($618.7K) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($725.4K) | Aug 7, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($836.3K) | Oct 23, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($902.6K) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($688.8K) | Apr 30, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($647.8K) | Oct 23, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($541.1K) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($903.6K) | Apr 30, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($512.8K) | Nov 4, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.12M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.05M) | May 20, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($582.7K) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($718.1K) | Aug 7, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($2.03M) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($445.9K) | Nov 7, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($543.2K) | Aug 8, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($604.8K) | May 11, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($240.6K) | Nov 15, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($1.17M) | Aug 13, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($290.7K) | May 17, 2021 |
| Q2 | 2018 | Jun 30, 2018 | ($464.9K) | Oct 1, 2018 |
| Q1 | 2018 | Mar 31, 2018 | ($736.3K) | May 11, 2018 |